The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Ostial sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Ostial is a medical equipment company that develops medical devices for the treatment of aorto-ostial interventions. Its product FLASH Aorto-Ostial Angioplasty System offers physicians the ability to confidently treat ostial cases with genuine 360 degree lesion coverage, facilitating streamlined vessel access and ensuring optimal patient outcomes. The company uses its proprietary novel dual-balloon technology to manufacture its products. Ostial is headquartered in Campbell, California, the US.
The key metrics of Ostial related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Ostial is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Ostial.
For a detailed understanding of the performance of Ostial, buy the report here.